While all analytical data that is used for decision-making needs to be of known and documented quality, the pharmaceutical industry particularly demands absolute results and extensive supportive documentation.The decisions based upon the analytical results that support drug discovery, development, and manufacturing can have significant repercussions on public health, product quality, regulatory compliance, and ultimately the drug manufacturer’s financial status. Services provided by Brooks Applied Labs have supported drug release testing, clean up efficiencies of catalysts, impurity identification, lot monitoring, and investigations into bioreactor performance variability for over a decade.
Through our experience with nearly all facets of the industry, our involvement has saved our clients hundreds of millions of dollars on method development/validation, synthesis inefficiencies, side product formation, API stability, and most importantly the ability to deliver life-saving drugs to patients who need it.
Scientists at Brooks Applied Labs have the knowledge and experience to identify the most appropriate techniques for analysis of the most complex pharmaceutical molecules and target elements as we have tested thousands of different materials over the years.
Brooks Applied Labs is continually being audited by our pharmaceutical clients, as well as the FDA, to ensure CGMP compliance and implementation, as well as execution of quality requirements set forth by the Code of Federal Regulations (CFR) and the International Conference on Harmonization (ICH). We understand our compliance equates to a level of quality that is essential to support your processes.
Contact us to find out how your quality and process objectives can be met more efficiently than ever or read more about our services by clicking on any of our brochures below.